Cargando…
A case of effective intravenous methylprednisolone pulse therapy against severe COVID‐19 infection after arteriovenous graft surgery
Perioperative COVID‐19 infections in patients suffering from end‐stage renal disease (ESRD) are more likely to become severe, with a high mortality rate, than those in other patients. For such patients, corticosteroid therapy is one of the limited number of treatment options. We experienced a case o...
Autores principales: | Kamata, Sokichi, Hamanaka, Souhei, Tsukamoto, Jin, Tsuchimoto, Teppei, Fujiwara, Kiyohiro, Okamura, Mikio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680016/ https://www.ncbi.nlm.nih.gov/pubmed/34976399 http://dx.doi.org/10.1002/rcr2.889 |
Ejemplares similares
-
Intravenous pulse methylprednisolone for the treatment of severe COVID-19
por: Patoulias, Dimitrios, et al.
Publicado: (2023) -
Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
por: Rymuza, Joanna, et al.
Publicado: (2018) -
Severe Adult Still's Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
por: Akiyama, Kaho, et al.
Publicado: (2021) -
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
por: Eguchi, Hiroyuki, et al.
Publicado: (2015) -
Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis
por: Ghoraba, Hashem H, et al.
Publicado: (2022)